Geographic Atrophy
📧 Sign up to get email alerts when something new happens for Geographic Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study
A completed clinical trial evaluating optical coherence tomography and microperimetry biomarkers in geographic atrophy due to age-related ma…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 1]
Phase 1 study evaluating tolerability of escalating doses of BI 771716 in people with geographic atrophy, an advanced form of age-related ma…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration [Phase 1]
Phase 1 study of ONL1204 Ophthalmic Solution for geographic atrophy associated with age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
A clinical trial evaluating the natural progression of dry age-related macular degeneration (AMD) sponsored by Gyroscope Therapeutics Limite…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of intravitreal ANX007 in geographic atrophy has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Geographic Atrophy Long-Terms Outcomes Study
Apellis Pharmaceuticals reports that the Geographic Atrophy Long-Term Outcomes Study has completed, providing long-term data related to geog…
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 clinical trial update for VOY-101 in advanced non-neovascular age-related macular degeneration and geographic atrophy.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial of Galegenimab (FHTR2163) in geographic atrophy due to age-related macular degeneration was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study [Phase 2]
A Phase 2 long-term follow-up study evaluating the safety of GT005 in participants with geographic atrophy secondary to age-related macular …
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration [Phase 2]
Phase 2 trial results update evaluating oral minocycline for geographic atrophy in age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) [Phase 3]
Phase 3 safety and efficacy study of intravitreal Zimura (avacincaptad pegol) for geographic atrophy and age-related macular degeneration ha…
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA [Phase 2]
Phase 2 trial results update for elamipretide in age-related macular degeneration with non-central geographic atrophy.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 2]
Phase 2 long-term safety and tolerability study of Galegenimab (FHTR2163) in geographic atrophy due to age-related macular degeneration has …
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy [Phase 1]
Phase 1 study evaluating tolerability of different doses of BI 754132 in geographic atrophy due to age-related macular degeneration; trial t…
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration [Phase 3]
Phase 3 trial comparing intravitreal APL-2 therapy to sham injections in geographic atrophy due to age-related macular degeneration has comp…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration [Phase 3]
Phase 3 trial comparing intravitreal APL-2 vs sham injections in geographic atrophy due to age-related macular degeneration has completed wi…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD [Phase 2]
Phase 2 trial evaluating metformin to slow geographic atrophy progression in age-related macular degeneration has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration [Phase 2, Phase 3]
A Phase 2/Phase 3 trial update for Zimura in geographic atrophy due to dry age-related macular degeneration. The study is completed and resu…
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy [Phase 2]
A Phase 2 study evaluating pegcetacoplan (APL-2) for geographic atrophy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy [Phase 2]
Phase 2 trial update on subretinal administration of CNTO 2476 in geographic atrophy, reporting safety and clinical response outcomes with r…
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD [Phase 1, Phase 2]
Clinical trial update for subretinal implantation of human embryonic stem cell-derived RPE cells in advanced dry AMD (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD [NA]
Completed results for a trial of subthreshold laser treatment for reticular pseudodrusen and geographic atrophy due to age-related macular d…
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 3]
Phase 3 trial of lampalizumab for geographic atrophy due to age-related macular degeneration was terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 2]
Phase 2 safety and efficacy trial of brimonidine intravitreal implant for geographic atrophy due to age-related macular degeneration was ter…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 3]
Phase 3 trial investigating lampalizumab for geographic atrophy due to age-related macular degeneration was terminated; results posted in 20…